Mendcure Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.26 M
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 3.03%
- Profit Growth 236.16%
- Ebitda 53.76%
- Net Worth 93.90%
- Total Assets -25.79%
About Mendcure Life Sciences
Mendcure Life Sciences Private Limited (MLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 March 2018 (Six years and 11 months 9 days old ). Its registered office is in Nashik, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.26 M, as per Ministry of Corporate Affairs (MCA) records.
Ronak Patel and Darshana Patel serve as directors at the Company.
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U01110MH2018PTC306822
- Company No.
306822
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2018
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Mendcure Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ronak Patel  | Director | 20-Mar-2018 | Current |
| Darshana Patel | Director | 03-Jan-2019 | Current |
Financial Performance of Mendcure Life Sciences.
Mendcure Life Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.03% increase. The company also saw a substantial improvement in profitability, with a 236.16% increase in profit. The company's net worth Soared by an impressive increase of 93.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mendcure Life Sciences?
In 2023, Mendcure Life Sciences had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Grimend Herbal Solutions LlpRonak Patel is a mutual person
- Shree Adinath Steel Private Limited
Ronak Patel is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mendcure Life Sciences?
Unlock and access historical data on people associated with Mendcure Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mendcure Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mendcure Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
